Report for: Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis

RT @RheumNow: If switching from po to subcut MTX (intolerance,efficacy) to improve bioavailability, best to maintain the same dose https://…

RT @RheumNow: If switching from po to subcut MTX (intolerance,efficacy) to improve bioavailability, best to maintain the same dose https://…

RT @RheumNow: If switching from po to subcut MTX (intolerance,efficacy) to improve bioavailability, best to maintain the same dose https://…

RT @RheumNow: If switching from po to subcut MTX (intolerance,efficacy) to improve bioavailability, best to maintain the same dose https://…

RT @RheumNow: If switching from po to subcut MTX (intolerance,efficacy) to improve bioavailability, best to maintain the same dose https://…

If switching from po to subcut MTX (intolerance,efficacy) to improve bioavailability, best to maintain the same dose https://t.co/qxZfTgo4Hq

If switching from po to subcut MTX (intolerance,efficacy) to improve bioavailability, best to maintain the same dose https://t.co/G1zLL72YYI

Dove Medical Press